| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Haughey Thomas is a Director at ANIP. Recent filings cover 4 purchases and 2 sales. Those positions are worth an estimated $3.1M at current prices.
Haughey Thomas's largest disclosed position is in ANIP as Director, worth about $3.1M. The recent filings there lean toward selling, a net 11,341 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | ANIP Ani Pharmaceuticals, Inc. | Director | Sell | 2,000 | $80.88 | $161,760.00 | -4.9% | -12.4% | - | |
| Aug 12, 2025 | ANIP Ani Pharmaceuticals Inc | Director | Sell | 19,341 | $85.93 | $1,661,972.13 | -34.6% | +0.7% | -15.0% | |
| Dec 6, 2021 | ANIP Ani Pharmaceuticals Inc | Director | Buy | 2,500 | $39.38 | $98,450.00 | +9.0% | -10.5% | -7.1% | |
| Mar 4, 2020 | ANIP Ani Pharmaceuticals Inc | Director | Buy | 5,000 | $45.10 | $225,510.00 | +79.5% | - | - | |
| May 15, 2019 | ANIP Ani Pharmaceuticals Inc | Director | Buy | 2,500 | $69.30 | $173,240.00 | +65.9% | - | - |